FDA warning letter to Empower puts compounded GLP-1s in focus
The FDA has sent one of the country's largest compounding pharmacies a warning letter focused on compounded GLP-1 weight loss medications. The…
The starter price on the ad is not what you pay at month two
The starter price on a GLP-1 ad is often a membership plus the drug by month two, or a bill that climbs…
New coalition pushes Congress on cross-state telehealth licensing
If you have ever moved, traveled or gone to college in another state, you may have found that your doctor suddenly could…
Blue Shield of California to more than double Virtual Blue in 2027
One of California's largest insurers is betting harder on virtual-first care. Blue Shield of California announced on September 17 that it will…
What Medicare’s 2027 fee schedule proposes for telehealth
The public comment period on Medicare's 2027 Physician Fee Schedule closed on September 14. The proposed rule, released by the Centers for…
DEA telemedicine rule reaches White House review
After more than 16 years of waiting, the Drug Enforcement Administration's telemedicine special registration rule has reached the last stop before publication.…
DOJ fraud division names telemedicine a 2026 priority
The Justice Department has put telemedicine on its short list. On August 13, Assistant Attorney General Colin M. McDonald issued a priorities…
“A two-minute video call and a box in the mail” is not care
A box in the mail is not care. What ongoing GLP-1 telehealth should actually include, and the questions to ask before you…